Anavex Life Sciences Corp. (AVXL) SEC Filings — 2025
9 SEC filings for Anavex Life Sciences Corp. (AVXL) in 2025.
Filings
- Anavex Faces EMA Setback on Alzheimer's Drug Blarcamesine — 10-K · Nov 25, 2025
- Anavex Life Sciences Corp. 8-K Filing — 8-K · Nov 14, 2025
- ANAVEX Q3: No Revenue, Continued R&D Spend — 10-Q · Aug 12, 2025
- Anavex Life Sciences Enters Material Definitive Agreement — 8-K · Jul 28, 2025
- Anavex Life Sciences Files 8-K: Board & Compensation Updates — 8-K · Jul 3, 2025
- Anavex Life Sciences Corp. Announces Board Changes and Shareholder Meeting — 8-K · Jun 13, 2025
- Anavex Life Sciences Files Q2 2025 10-Q — 10-Q · May 13, 2025
- Anavex Life Sciences Files Definitive Proxy Statement — DEF 14A · Apr 25, 2025
- Anavex Life Sciences Files Q1 2025 10-Q — 10-Q · Feb 12, 2025